A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects.
PHASE1CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
May 31, 2016
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Conditions
AnesthesiaSedation
Interventions
DRUG
HSK3486
Mmanual IV bolus injection completed in 1 minute.
All Listed Sponsors
lead
Sichuan Haisco Pharmaceutical Group Co., Ltd
INDUSTRY
NCT03773835 - A Study Evaluating Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Single IV Dose of HSK3486 Injectable Emulsion in Healthy Subjects. | Biotech Hunter | Biotech Hunter